COSMO Pharmaceuticals SA Tangible Net Worth Ratio
COSMO Pharmaceuticals SA tangible net worth ratio. COSMO Pharmaceuticals SA (0RGI) has a Tangible Net Worth Ratio of 43.7% as of June 2026. This metric is calculated by deducting intangible assets (£323.04 Million) from net assets (£573.73 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 0RGI shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of COSMO Pharmaceuticals SA (2005–2025)
Tangible net worth ratio of COSMO Pharmaceuticals SA from 2005 to 2025. This chart shows how COSMO Pharmaceuticals SA's Tangible Net Worth Ratio has changed across 21 annual periods from 2005 to 2025. As of June 2026, the ratio stands at 43.7%, reflecting net assets of £573.73 Million with intangible assets of £323.04 Million GBP. Check strategic asset allocation of COSMO Pharmaceuticals SA to assess the company's strategic physical and investment asset allocation.
COSMO Pharmaceuticals SA Tangible Net Worth Ratio by Year (2005–2025)
COSMO Pharmaceuticals SA tangible net worth ratio by year from 2005 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for COSMO Pharmaceuticals SA from 2005 to 2025, covering 21 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see COSMO Pharmaceuticals SA stock valuation.
| Year | Tangible NW Ratio | Net Assets (GBP) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 33.4% | £488.80 Million | £325.63 Million | £612.16 Million | ▼ -34.6 pp |
| 2024 | 68.0% | £505.09 Million | £161.66 Million | £646.77 Million | ▲ +50.9 pp |
| 2023 | 17.1% | £429.04 Million | £355.62 Million | £553.98 Million | ▼ -5.1 pp |
| 2022 | 22.2% | £463.79 Million | £360.88 Million | £759.59 Million | ▼ -5.8 pp |
| 2021 | 28.0% | £512.68 Million | £369.31 Million | £805.56 Million | ▼ -71.2 pp |
| 2020 | 99.2% | £400.12 Million | £3.24 Million | £596.16 Million | ▲ +4.7 pp |
| 2019 | 94.5% | £393.73 Million | £21.67 Million | £585.16 Million | ▼ -2.4 pp |
| 2018 | 96.9% | £444.85 Million | £13.96 Million | £625.69 Million | ▼ -0.2 pp |
| 2017 | 97.1% | £470.12 Million | £13.82 Million | £497.97 Million | ▲ +0.4 pp |
| 2016 | 96.7% | £415.56 Million | £13.78 Million | £443.47 Million | ▼ -2.2 pp |
| 2015 | 98.9% | £403.65 Million | £4.50 Million | £437.94 Million | ▲ +2.0 pp |
| 2014 | 96.9% | £152.29 Million | £4.70 Million | £225.62 Million | ▼ -0.8 pp |
| 2013 | 97.7% | £220.16 Million | £5.14 Million | £243.00 Million | ▲ +2.0 pp |
| 2012 | 95.7% | £150.41 Million | £6.45 Million | £183.30 Million | ▲ +30.3 pp |
| 2011 | 65.4% | £63.43 Million | £21.97 Million | £78.04 Million | ▲ +0.3 pp |
| 2010 | 65.1% | £58.37 Million | £20.39 Million | £91.83 Million | ▼ -14.8 pp |
| 2009 | 79.9% | £59.80 Million | £12.04 Million | £71.46 Million | ▼ -4.3 pp |
| 2008 | 84.1% | £43.24 Million | £6.86 Million | £57.77 Million | ▼ -6.8 pp |
| 2007 | 91.0% | £35.15 Million | £3.17 Million | £47.23 Million | ▲ +54.3 pp |
| 2006 | 36.7% | £5.34 Million | £3.38 Million | £23.61 Million | ▲ +83.7 pp |
| 2005 | -47.1% | £631.00K | £928.00K | £28.21 Million | — |